We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNRX icon
11926
PUT
VolitionRx Ltd
VNRX
$6.48M
$123K ﹤0.01%
1,965
-55
-3% -$3.75K
WKSP icon
11927
CALL
Worksport
WKSP
$8.8M
$123K ﹤0.01%
5,080
-22,620
-82% -$1.01M
SUNW
11928
CALL
DELISTED
Sunworks, Inc.
SUNW
$123K ﹤0.01%
40,200
-44,800
-53% -$229K
SPK
11929
DELISTED
SPK Acquisition Corp. Common Stock
SPK
$123K ﹤0.01%
+12,380
New +$123K
ALIT icon
11930
CALL
Alight
ALIT
$374M
$122K ﹤0.01%
565
-31,930
-98% -$6.93M
AVTX icon
11931
CALL
Avalo Therapeutics
AVTX
$1.05B
$122K ﹤0.01%
25
-4
-14% -$24K
UAVS icon
11932
PUT
AgEagle Aerial Systems
UAVS
$67.9M
$122K ﹤0.01%
78
-61
-44% -$148K
SPRB
11933
Spruce Biosciences
SPRB
$175M
$122K ﹤0.01%
+364
New +$108K
TCON
11934
PUT
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$122K ﹤0.01%
2,195
+840
+62% +$53.6K
EDI
11935
DELISTED
Virtus Stone Harbor Emerging Markets Total Income Fund
EDI
$122K ﹤0.01%
+15,597
New +$126K
ATRS
11936
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$122K ﹤0.01%
34,200
-24,200
-41% -$84.6K
HDSN
11937
PUT
Hudson Technologies
HDSN
$229M
$121K ﹤0.01%
+27,300
New +$106K
MDWD icon
11938
MediWound
MDWD
$163M
$121K ﹤0.01%
+7,298
New +$152K
ACOR
11939
PUT
DELISTED
Acorda Therapeutics
ACOR
$121K ﹤0.01%
2,525
+1,345
+114% +$92.7K
EMKR
11940
DELISTED
Emcore Corp
EMKR
$121K ﹤0.01%
1,734
-550
-24% -$40.5K
BZFD icon
11941
PUT
BuzzFeed
BZFD
$103M
$120K ﹤0.01%
+5,650
New +$199K
APRN
11942
PUT
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$120K ﹤0.01%
1,483
-8,225
-85% -$857K
CPUH
11943
PUT
DELISTED
Compute Health Acquisition Corp.
CPUH
$120K ﹤0.01%
+12,300
New +$120K
MACK
11944
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$120K ﹤0.01%
30,600
-7,300
-19% -$31.7K
GGN
11945
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$881M
$119K ﹤0.01%
+31,649
New +$121K
PRQR icon
11946
PUT
ProQR Therapeutics
PRQR
$323M
$119K ﹤0.01%
14,800
-42,700
-74% -$325K
QIPT
11947
DELISTED
Quipt Home Medical
QIPT
$119K ﹤0.01%
+21,275
New +$124K
STGW icon
11948
CALL
Stagwell
STGW
$2.14B
$119K ﹤0.01%
13,700
-10,600
-44% -$91.2K
KBNT
11949
CALL
DELISTED
Kubient, Inc. Common Stock
KBNT
$119K ﹤0.01%
39,500
+21,500
+119% +$64.1K
SGTX
11950
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$119K ﹤0.01%
3,317
+1,446
+77% +$82.3K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.